{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:23:19Z","timestamp":1763749399354,"version":"3.28.0"},"reference-count":59,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pulmonary hypertension (PH) is a vascular disease characterized by pulmonary artery remodeling and right heart failure. PH related to COPD is a precapillary form of the disease, with hemodynamic measurements including a mean pulmonary artery pressure of greater than 20\u2009mm Hg, a wedge pressure of less than 15\u2009mm Hg, and a pulmonary vascular resistance of greater than 3 WU (Woods units), categorized under the World Health Organization classification as group 3. The presence of PH in COPD has been known to increase morbidity and mortality. Limited studies have evaluated treatment options for PH related to COPD.<\/jats:p>","DOI":"10.1055\/s-0044-1791824","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T23:32:24Z","timestamp":1731454344000},"page":"574-581","source":"Crossref","is-referenced-by-count":1,"title":["Pulmonary Vascular Disease in Chronic Obstructive Pulmonary Disease"],"prefix":"10.1055","volume":"45","author":[{"given":"Dana","family":"Kay","sequence":"additional","affiliation":[{"name":"College of Medicine, University of Cincinnati, Cincinnati, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Bernardo","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Elwing","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"issue":"03","key":"ref1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1164\/rccm.2107027","article-title":"Hemodynamic characterization of patients with severe emphysema","volume":"166","author":"S M Scharf","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/thx.36.10.752","article-title":"Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease","volume":"36","author":"E Weitzenblum","year":"1981","journal-title":"Thorax"},{"issue":"05","key":"ref3","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1378\/chest.127.5.1531","article-title":"Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation","volume":"127","author":"G Thabut","year":"2005","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000195950","article-title":"Pulmonary hemodynamics in chronic obstructive pulmonary disease of the emphysematous type","volume":"58","author":"M Oswald-Mammosser","year":"1991","journal-title":"Respiration"},{"issue":"03","key":"ref5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/thx.43.3.183","article-title":"Pulmonary vascular structure and function in chronic obstructive pulmonary disease","volume":"43","author":"F Magee","year":"1988","journal-title":"Thorax"},{"issue":"17","key":"ref6","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1161\/CIRCULATIONAHA.106.632208","article-title":"Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure","volume":"114","author":"N F Voelkel","year":"2006","journal-title":"Circulation"},{"issue":"08","key":"ref7","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1172\/JCI102662","article-title":"Effects of acute anoxia on the circulation and respiration in patients with chronic pulmonary disease studied during the steady state","volume":"31","author":"A P Fishman","year":"1952","journal-title":"J Clin Invest"},{"issue":"02","key":"ref8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1096\/fasebj.9.2.7781921","article-title":"The mechanism of acute hypoxic pulmonary vasoconstriction: the tale of two channels","volume":"9","author":"E K Weir","year":"1995","journal-title":"FASEB J"},{"issue":"05","key":"ref9","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1159\/000067463","article-title":"Effects of hemoglobin on pulmonary arterial pressure and pulmonary vascular resistance in patients with chronic emphysema","volume":"67","author":"A Nakamura","year":"2000","journal-title":"Respiration"},{"issue":"02","key":"ref10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1378\/chest.130.2.326","article-title":"Systemic inflammation in patients with COPD and pulmonary hypertension","volume":"130","author":"P Joppa","year":"2006","journal-title":"Chest"},{"issue":"04","key":"ref11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1164\/ajrccm.164.4.2101023","article-title":"Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers","volume":"164","author":"J A Barber\u00e0","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1164\/ajrccm.159.5.9807059","article-title":"Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease","volume":"159","author":"V I Peinado","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/01.LAB.0000032806.45023.08","article-title":"Cigarette smoke induces rapid changes in gene expression in pulmonary arteries","volume":"82","author":"J L Wright","year":"2002","journal-title":"Lab Invest"},{"key":"ref14","first-page":"H347","article-title":"Effects of acidosis and alkalosis on hypoxic pulmonary vasoconstriction in dogs","volume":"258","author":"S Brimioulle","year":"1990","journal-title":"Am J Physiol"},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/01.RES.52.1.76","article-title":"Right ventricular performance during increased afterload impaired by hypercapnic acidosis in conscious dogs","volume":"52","author":"C E Rose Jr","year":"1983","journal-title":"Circ Res"},{"issue":"02","key":"ref16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1183\/09031936.01.00078801","article-title":"Chronic intermittent hypercapnic hypoxia increases pulmonary arterial pressure and haematocrit in rats","volume":"18","author":"M McGuire","year":"2001","journal-title":"Eur Respir J"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.resp.2019.01.003","article-title":"Borderline pulmonary hypertension associated with chronic hypercapnia in chronic pulmonary disease","volume":"262","author":"L Zuoyou","year":"2019","journal-title":"Respir Physiol Neurobiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00508-005-0333-z","article-title":"The link between angiotensin-converting enzyme genotype and pulmonary artery pressure in patients with COPD","volume":"117","author":"R Tk\u00e1cov\u00e1","year":"2005","journal-title":"Wien Klin Wochenschr"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.rmed.2003.06.001","article-title":"Gene polymorphisms of endothelial nitric oxide synthase enzyme associated with pulmonary hypertension in patients with COPD","volume":"97","author":"P Yildiz","year":"2003","journal-title":"Respir Med"},{"issue":"08","key":"ref20","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1172\/JCI200112805","article-title":"Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension","volume":"108","author":"S Eddahibi","year":"2001","journal-title":"J Clin Invest"},{"issue":"05","key":"ref21","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1183\/09031936.00015608","article-title":"Pulmonary hypertension in COPD","volume":"32","author":"A Chaouat","year":"2008","journal-title":"Eur Respir J"},{"issue":"25","key":"ref22","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMra2000348","article-title":"Pulmonary Arterial Hypertension","volume":"385","author":"P M Hassoun","year":"2021","journal-title":"N Engl J Med"},{"issue":"02","key":"ref23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/2045894021999960","article-title":"Impact of the new definition for pulmonary hypertension in patients with lung disease: an analysis of the United Network for Organ Sharing database","volume":"11","author":"S D Nathan","year":"2021","journal-title":"Pulm Circ"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1183\/13993003.01914-2018","article-title":"Pulmonary hypertension in chronic lung disease and hypoxia","volume":"53","author":"S D Nathan","year":"2019","journal-title":"Eur Respir J"},{"issue":"05","key":"ref25","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.21037\/cdt-20-479","article-title":"Mechanics of right ventricular dysfunction in pulmonary arterial hypertension and heart failure with preserved ejection fraction","volume":"10","author":"R J Bernardo","year":"2020","journal-title":"Cardiovasc Diagn Ther"},{"issue":"06","key":"ref26","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s10554-017-1069-3","article-title":"Investigating the value of right heart echocardiographic metrics for detection of pulmonary hypertension in patients with advanced lung disease","volume":"33","author":"M Amsallem","year":"2017","journal-title":"Int J Cardiovasc Imaging"},{"issue":"02","key":"ref27","doi-asserted-by":"crossref","first-page":"e011464","DOI":"10.1161\/JAHA.118.011464","article-title":"Clinical determinants and prognostic implications of right ventricular dysfunction in pulmonary hypertension caused by chronic lung disease","volume":"8","author":"K W Prins","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"05","key":"ref28","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1165\/rcmb.2020-0023OC","article-title":"Role of hypoxia-inducible factors in regulating right ventricular function and remodeling during chronic hypoxia-induced pulmonary hypertension","volume":"63","author":"K A Smith","year":"2020","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"01","key":"ref29","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"M Humbert","year":"2023","journal-title":"Eur Respir J"},{"issue":"12","key":"ref30","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1513\/AnnalsATS.202303-216OC","article-title":"Impact on pulmonary hypertension hemodynamic classification based on the methodology used to measure pulmonary artery wedge pressure and cardiac output","volume":"20","author":"S Sahay","year":"2023","journal-title":"Ann Am Thorac Soc"},{"issue":"09","key":"ref31","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/CIRCULATIONAHA.119.040295","article-title":"Differentiating precapillary from postcapillary pulmonary hypertension","volume":"140","author":"R Naeije","year":"2019","journal-title":"Circulation"},{"issue":"01","key":"ref32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1183\/13993003.01897-2018","article-title":"Pulmonary hypertension due to left heart disease","volume":"53","author":"J L Vachi\u00e9ry","year":"2019","journal-title":"Eur Respir J"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2401200","DOI":"10.1183\/13993003.01200-2024","article-title":"Pulmonary hypertension associated with lung diseases","author":"O A Shlobin","year":"2024","journal-title":"Eur Respir J"},{"issue":"04","key":"ref34","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"46","author":"N Gali\u00e8","year":"2015","journal-title":"Eur Respir J"},{"issue":"02","key":"ref35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1164\/rccm.200401-006OC","article-title":"Severe pulmonary hypertension and chronic obstructive pulmonary disease","volume":"172","author":"A Chaouat","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"08","key":"ref36","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1159\/000524263","article-title":"The effect of borderline pulmonary hypertension on survival in chronic lung disease","volume":"101","author":"L Piccari","year":"2022","journal-title":"Respiration"},{"issue":"02","key":"ref37","doi-asserted-by":"crossref","first-page":"2100944","DOI":"10.1183\/13993003.00944-2021","article-title":"Elevated pulmonary vascular resistance predicts mortality in COPD patients","volume":"58","author":"K Zeder","year":"2021","journal-title":"Eur Respir J"},{"issue":"08","key":"ref38","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1164\/rccm.201801-0095PP","article-title":"Pulmonary vascular involvement in chronic obstructive pulmonary disease. Is there a pulmonary vascular phenotype?","volume":"198","author":"G Kovacs","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"ref39","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.healun.2020.09.011","article-title":"Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry","volume":"39","author":"M M Hoeper","year":"2020","journal-title":"J Heart Lung Transplant"},{"issue":"02","key":"ref40","first-page":"273","article-title":"Morphologic changes in the muscular pulmonary arteries: relationship to cigarette smoking, airway disease, and emphysema","volume":"122","author":"K A Hale","year":"1980","journal-title":"Am Rev Respir Dis"},{"issue":"04","key":"ref41","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1183\/09031936.02.00245902","article-title":"Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD","volume":"19","author":"S Santos","year":"2002","journal-title":"Eur Respir J"},{"issue":"02","key":"ref42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1164\/rccm.201301-0162OC","article-title":"Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications","volume":"188","author":"R S Est\u00e9par","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"05","key":"ref43","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1161\/HYPERTENSIONAHA.119.14608","article-title":"Effects of chronic nicotine inhalation on systemic and pulmonary blood pressure and right ventricular remodeling in mice","volume":"75","author":"J M Oakes","year":"2020","journal-title":"Hypertension"},{"issue":"8222","key":"ref44","first-page":"681","article-title":"Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party","volume":"1","year":"1981","journal-title":"Lancet"},{"issue":"01","key":"ref45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1378\/chest.113.1.65","article-title":"Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: a 6-year prospective study","volume":"113","author":"J Zieli\u0144ski","year":"1998","journal-title":"Chest"},{"issue":"04","key":"ref46","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1164\/arrd.1985.131.4.493","article-title":"Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease","volume":"131","author":"E Weitzenblum","year":"1985","journal-title":"Am Rev Respir Dis"},{"issue":"03","key":"ref47","doi-asserted-by":"crossref","first-page":"391","DOI":"10.7326\/0003-4819-93-3-391","article-title":"Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial","volume":"93","author":"Nocturnal Oxygen Therapy Trial Group","year":"1980","journal-title":"Ann Intern Med"},{"issue":"01","key":"ref48","doi-asserted-by":"crossref","first-page":"00348-2021","DOI":"10.1183\/23120541.00348-2021","article-title":"Treatment of pulmonary hypertension associated with COPD: a systematic review","volume":"8","author":"R Arif","year":"2022","journal-title":"ERJ Open Res"},{"issue":"15","key":"ref49","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/eurheartj\/ehad005","article-title":"Corrigendum to: 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG)","volume":"44","author":"M Humbert","year":"2023","journal-title":"Eur Heart J"},{"issue":"01","key":"ref50","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1164\/ajrccm\/139.1.120","article-title":"Nifedipine reduces pulmonary pressure and vascular tone during short- but not long-term treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease","volume":"139","author":"P Agostoni","year":"1989","journal-title":"Am Rev Respir Dis"},{"issue":"02","key":"ref51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000195514","article-title":"One-year clinical study on nifedipine in the treatment of pulmonary hypertension in chronic obstructive lung disease","volume":"54","author":"R Vestri","year":"1988","journal-title":"Respiration"},{"issue":"02","key":"ref52","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.healun.2016.04.010","article-title":"Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: a randomized controlled multicenter clinical trial","volume":"36","author":"P Vitulo","year":"2017","journal-title":"J Heart Lung Transplant"},{"issue":"03","key":"ref53","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3109\/15412555.2011.651180","article-title":"Sildenafil for chronic obstructive pulmonary disease: a randomized crossover trial","volume":"9","author":"D J Lederer","year":"2012","journal-title":"COPD"},{"issue":"04","key":"ref54","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S2213-2600(14)70013-X","article-title":"Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial","volume":"2","author":"A R Goudie","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"03","key":"ref55","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1183\/09031936.00011308","article-title":"A randomised, controlled trial of bosentan in severe COPD","volume":"32","author":"D Stolz","year":"2008","journal-title":"Eur Respir J"},{"issue":"06","key":"ref56","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1183\/09031936.00079512","article-title":"Pulmonary hypertension in COPD: results from the ASPIRE registry","volume":"41","author":"J Hurdman","year":"2013","journal-title":"Eur Respir J"},{"issue":"02","key":"ref57","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.chest.2021.02.012","article-title":"Pulmonary hypertension in patients with COPD: results from the comparative, prospective registry of newly initiated therapies for pulmonary hypertension (COMPERA)","volume":"160","author":"C D Vizza","year":"2021","journal-title":"Chest"},{"key":"ref58","first-page":"S0012","article-title":"Phosphodiesterase-5 inhibitor treatment is associated with improved survival in pulmonary hypertension associated with COPD in the PVRI GoDeep meta-registry","author":"K Tello","year":"2024","journal-title":"Chest"},{"issue":"06","key":"ref59","doi-asserted-by":"crossref","first-page":"2400172","DOI":"10.1183\/13993003.00172-2024","article-title":"Inhaled treprostinil in pulmonary hypertension associated with COPD: PERFECT study results","volume":"63","author":"S D Nathan","year":"2024","journal-title":"Eur Respir J"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1791824.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T23:33:36Z","timestamp":1731454416000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1791824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":59,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2024,11,12]]},"published-print":{"date-parts":[[2024,10]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1791824","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}